Literature DB >> 1091356

The fate of injected human IgG in the mouse liver: Uptake, immunological inactivation, and lysosomal reactions.

D Mitrenga, W Arnold, O Müller, H V Mayersbach.   

Abstract

1. Human IgG is stored in the form of remarkable droplets in the cytoplasm of mouse hepatocytes following intravenous injection. 2. The earliest protein uptake occurs within 1 minute after injection and droplets can be found up to 32 hours thereafter; 64 hours p.i. the foreign protein is no longer visible in hepatocytes. 3. Electron microscopy reveals that the uptake occurs by a process of "macropinocytosis". The resulting protein droplets fuse with primary lysosomes and are transformed into phagolysosomes. 4. At the same time as the phagolysosomes are formed the IgG-droplets loose their immunological activity--as early as 2 hours after injection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091356     DOI: 10.1007/bf00225364

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  19 in total

1.  The metabolism of fluorescein-labelled and unlabelled egg-white in the renal tubules of the mouse.

Authors:  H MAYERSBACH; A G PEARSE
Journal:  Br J Exp Pathol       Date:  1956-02

2.  The intracellular distribution in rabbit liver of injected antigens labeled with I131.

Authors:  C F CRAMPTON; F HAUROWITZ
Journal:  Science       Date:  1950-09-15       Impact factor: 47.728

3.  Methods for the study of small phagosomes and their relationship to lysosomes with horseradish peroxidase as a "marker protein".

Authors:  W Straus
Journal:  J Histochem Cytochem       Date:  1967-07       Impact factor: 2.479

4.  Changes in the solubility of immunoglobulins after fluorescent labeling and its influence on immunofluorescent techniques.

Authors:  W Arnold; H von Mayersbach
Journal:  J Histochem Cytochem       Date:  1972-12       Impact factor: 2.479

5.  The uptake and transport of exogenous proteins in mouse liver. Ultrastructural cytochemical studies with peroxidase tracers.

Authors:  R C Graham; S Limpert; R W Kellermeyer
Journal:  Lab Invest       Date:  1969-03       Impact factor: 5.662

6.  The preservation of substance and immunological activity of intra venously injected human IgG in the mouse liver. (Comparative studies on various tissue preparation and fixation methods).

Authors:  W Arnold; D Mitrenga; H van Mayersbach
Journal:  Acta Histochem       Date:  1974       Impact factor: 2.479

7.  Localization of antigen in tissue cells. VI. The fate of injected foreign proteins in the mouse.

Authors:  A H COONS; E H LEDUC; M H KAPLAN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

8.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02

9.  Hemoglobin uptake by rat hepatocytes and its breakdown within lysosomes.

Authors:  S Goldfischer; A B Novikoff; A Albala; L Biempica
Journal:  J Cell Biol       Date:  1970-03       Impact factor: 10.539

View more
  6 in total

1.  The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab].

Authors:  H H Sedlacek; P Gronski; T Hofstaetter; E J Kanzy; H U Schorlemmer; F R Seiler
Journal:  Klin Wochenschr       Date:  1983-08-01

2.  Enzymatic and functional heterogeneity of lysosomes.

Authors:  V Groh; H von Mayersbach
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

3.  [Problems of intravenous gammaglobulin therapy (author's transl)].

Authors:  J Ring; K H Duswald
Journal:  Klin Wochenschr       Date:  1980-08-15

4.  Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions.

Authors:  Ralf Schilling; Samreen Ijaz; Michail Davidoff; Jia Yee Lee; Stephen Locarnini; Roger Williams; Nikolai V Naoumov
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  Detection of liver IgG Fc receptors using soluble immune complexes of peroxidase-antiperoxidase. I. Detection in liver tissue from patients with liver diseases.

Authors:  T Shinohara
Journal:  Gastroenterol Jpn       Date:  1981

Review 6.  Stepping forward in antibody-drug conjugate development.

Authors:  Yiming Jin; Megan A Schladetsch; Xueting Huang; Marcy J Balunas; Andrew J Wiemer
Journal:  Pharmacol Ther       Date:  2021-06-24       Impact factor: 12.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.